In conclusion, we demonstrated that tumors with higher expression of p16INK4 and RB1 were statistically significantly associated with unfavorable outcomes in patients with stage I and II nonsquamous NSCLC. The gene discussed is RB1; the disease is non-small cell lung carcinoma.